CD8A and neoplasm: Therefore, CD3xEpCAM antibody binds to both mouse CD3ɛ and human EpCAM and redirects OT1 T cells to kill B16/EpCAM tumor cells in a target-specific manner by essentially changing the CD8 T cell specificity from OVA to EpCAM.